Xylocaine 5%

Quick links

Choose a section

Quick links to important sections

Advertisements

Xylocaine 5%

Advertisements

Overview of Xylocaine 5%

Quick Facts: Xylocaine 5% Ointment

Property Description
Active Ingredient Lidocaine Hydrochloride (INN)
Form Ointment (Semisolid, topical preparation)
Pharmacological Class Local Anesthetic (Amide-Type)
Common Use Inducing Surface Anesthesia and Dermal Analgesia
Origin Synthetic Compound

What Type of Medicine is Xylocaine 5%?

Xylocaine 5% Ointment is a synthetic, topical pharmaceutical preparation classified as an amide-type local anesthetic, designed to induce temporary, localized sensation loss. Its sole active ingredient is Lidocaine Hydrochloride, which is chemically manufactured and standardized at a five percent (5%) concentration within the formula. This specific concentration and formulation are recognized for delivering effective surface anesthesia. As a single-active ingredient product, its pharmacological profile is focused entirely on the action of Lidocaine, setting it apart from combination anesthetic products.


The Form and General Purpose

The medicine is supplied in the dosage form of an ointment, which is a semisolid matrix designed specifically for topical administration onto the exterior surface of the skin or accessible mucous membranes. The ointment base, comprised of the active Lidocaine Hydrochloride and non-active excipients like polyethylene glycols, facilitates adherence and sustained contact at the application site. The general purpose of this topical preparation is to provide rapid and targeted pain relief by inducing surface anesthesia and dermal analgesia. This is achieved by the compound's ability to temporarily interrupt the electrical signaling necessary for transmitting sensations. This topical route for local anesthetics ensures the anesthetic effect is contained within the treatment area and minimizes systemic absorption.

Regulatory References

  1. Lidocaine Topical Patch: MedlinePlus Drug Information
  2. Guideline on quality and equivalence of locally applied, locally acting cutaneous products
Advertisements

What side effects are possible with Xylocaine 5%?

Possible Side Effects and Safety Information

Official regulatory documentation classifies the potential safety characteristics of Lidocaine 5% Ointment into local effects and those that may occur if the medicine is absorbed excessively, leading to systemic exposure. The most common adverse reactions are typically confined to the site of application.

Adverse Reactions and Frequency Classification

The most frequent effects are generally classified as Common and involve the Skin and Subcutaneous Tissue Disorders. These include application site reactions such as erythema (redness), pruritus (itching), irritation, and a burning sensation. Less common reactions may include systemic allergic responses, sometimes classified as Rare, such as urticaria or edema.

Serious Systemic Safety Concerns

Adverse reactions affecting major organ systems are typically associated with high plasma concentrations of Lidocaine, often resulting from excessive dosage or rapid absorption through broken skin. The officially documented serious reactions, while rare, involve effects on the Central Nervous System (CNS) and the Cardiovascular System (CVS). These include CNS toxicity that may lead to convulsions or respiratory arrest, and CVS toxicity potentially leading to cardiac arrest or cardiovascular collapse. Additionally, a rare but serious blood disorder called Methemoglobinemia is cited in official regulatory warnings.

Population-Specific Considerations

The official safety profile highlights heightened risk for certain populations. Individuals with severe hepatic disease are at greater risk of toxic blood concentrations due to reduced drug metabolism. Infants under six months of age and patients with specific genetic factors like G6PD deficiency are noted as being more susceptible to Methemoglobinemia.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information describes overdose from topical Lidocaine as the result of systemic toxicity following high plasma concentrations. Manifestations primarily affect the Central Nervous System (CNS) and the Cardiovascular System.

Documented Overdose Manifestations

Element Official Regulatory Description
CNS Signs (Early) Symptoms may begin with prodromal signs such as metallic taste, tinnitus (ringing in the ears), dizziness, confusion, drowsiness, and tremors [DailyMed Labeling].
Severe Outcomes CNS excitation may rapidly progress to convulsions, unconsciousness, and respiratory arrest. Cardiovascular toxicity is depressant, leading to bradycardia, hypotension, and cardiac arrest [DailyMed Labeling].
Metabolic Risk Overexposure carries a risk of Methemoglobinemia, signaled by cyanotic skin discoloration (pale, gray, or blue skin), shortness of breath, headache, and rapid heart rate [DailyMed Labeling].

Required Emergency Actions

  • Seek immediate medical attention if any signs or symptoms of Methemoglobinemia are observed, or if severe CNS manifestations such as a seizure or collapse occur [DailyMed Labeling].
  • Management of serious toxicity requires immediate attention to establishing a patent airway, providing assisted or controlled ventilation with oxygen, and the availability of resuscitative equipment and drugs [DailyMed Labeling].
  • Constant monitoring of the patient's cardiovascular and respiratory vital signs and state of consciousness is required [DailyMed Labeling].
  • Patients with severe hepatic disease, the elderly, and acutely ill patients are noted in official labeling as being at increased risk for toxicity [DailyMed Labeling].
Advertisements

Therapeutic Uses of Xylocaine 5%

What Xylocaine 5% Treats: Main Uses and Benefits

The primary role of Lidocaine Ointment 5% is to provide localized symptomatic relief across distinct clinical domains, focusing entirely on surface-level distress and discomfort.

Lidocaine Ointment 5% is commonly used to help manage acute or recurrent symptomatic episodes involving superficial distress. It is relevant when supportive symptom management is appropriate in conditions such as hemorrhoids, anal fissures, minor burns (including sunburn), and abrasions. This therapeutic action helps address symptom clusters that may become intense or disruptive, specifically managing the localized pain, burning, and soreness often linked to inflammatory or irritative states. The medication is applied for conditions presenting with disruptive symptom manifestations.

Quick Fact: Relief for Localized Discomfort

Symptom Domain Conditions Supported Primary Therapeutic Benefit
Pain, Soreness, Burning Anorectal disorders (Hemorrhoids, Fissures) Eases overall symptom load, supports comfort
Superficial Tenderness Minor trauma (Sunburn, Abrasions) Provides short-term localized symptomatic support
Acute Sensitivity Pre-procedure preparation Assists with maintaining functional stability for interventions

Regulatory References

  1. NIH DailyMed information
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Xylocaine 5%?

The eligibility for using Xylocaine 5% Ointment is strictly defined by regulatory warnings and contraindications related to patient health status and age.


Absolute Contraindications

The medicine is formally contraindicated and must not be used in individuals with a known history of hypersensitivity or allergy to lidocaine or other local anesthetics of the amide type. Use is also prohibited in patients experiencing severe shock or heart block. Application to severely traumatized mucosa or in the presence of sepsis at the site is restricted due to the potential for rapid systemic absorption.


Restricted Use Populations

Use is conditional and requires caution or dose adjustment in several populations. Elderly, acutely ill, and debilitated patients must receive reduced amounts, commensurate with their physical status, to avoid high systemic levels. Patients with severe hepatic disease are restricted due to the liver's inability to metabolize lidocaine efficiently. Eligibility is also limited for those with certain blood conditions, such as G6PD deficiency.


Age and Reproductive Status

Population Group Regulatory Status
Children Under 2 Years Use not recommended (insufficient data)
Acutely Ill / Elderly Use restricted (requires reduced dose)
Pregnancy (FDA) Category B (Use if benefit justifies risk)
Lactation Conditional use (passes into milk in small amounts)
Advertisements

What should I know about interactions with other medicines?

Interaction Map: Xylocaine 5% Interactions with other medicines and products

Interaction Scope

Medicinal product categories with documented interactions include other local anesthetics and Class I antiarrhythmic drugs (such as Tocainide and Mexiletine), which present an official risk of additive systemic toxicity. Concurrent use is also documented with various methemoglobinemia-associated agents, including nitrates, nitrites, certain antineoplastic agents, and sulfonamide antibiotics. The documented mechanistic basis for interactions with other local anesthetics is a pharmacodynamic effect leading to additive toxicity.

Interaction-Related Restrictions and Classifications

Co-administration with other lidocaine-containing products requires consideration of the total cumulative dose, as regulatory documents state that the toxic effects are additive. The most significant interactions are classified based on the potential for Additive Systemic Toxicity (neurologic and cardiovascular events) and Increased Risk of Methemoglobinemia.

Population-specific interaction notes are explicitly stated for patients with severe hepatic disease, where reduced metabolic clearance amplifies the risk of toxic blood concentrations. Furthermore, a formal contraindication exists for infants 12 months of age or younger who require treatment with other methemoglobin-inducing agents.


Resulting Interaction Structure

The regulatory profile defines the interaction structure by identifying substances that lead to an increased systemic burden, either through additive pharmacodynamic effects or by inhibiting the body's natural clearance processes. This focus highlights the documented risks associated with increased systemic exposure of the active ingredient and concurrent exposure to specific oxidizing agents.

Advertisements

Mechanism of Action

Blocking the Voltage-Gated Sodium Channel ( Na v)

The core mechanism of Lidocaine is its function as a physical inhibitor of the Voltage-Gated Sodium Channels ( Na v) on the membranes of peripheral sensory neurons. After gaining entry into the nerve cell, the Lidocaine molecule binds to a receptor site inside the channel pore, which physically obstructs the path for sodium ions ( Na^+). This targeted molecular action prevents the necessary rapid influx of Na^+ that would normally trigger the nerve's electrical discharge.


Interruption of Afferent Signal Conduction

By halting the influx of sodium ions, Lidocaine prevents the nerve membrane from undergoing the necessary depolarization required to generate an action potential. This interruption of the nerve's electrical cascade ensures that sensory signals, particularly those carried by A- delta and C-fibers, cannot propagate along the peripheral nerve fiber and reach the central nervous system. The resulting physiological effect is a localized, reversible interruption of afferent sensory impulse transmission at the application site.


Constraints on Mechanism Efficacy

The performance of the Na v channel block is constrained by the drug's requirement to cross the nerve membrane as its uncharged form. In biological scenarios where the tissue pH is low (more acidic, such as in inflamed or infected tissue), the molecule shifts predominantly to its charged form outside the nerve cell. This physicochemical limitation reduces the quantity of drug able to access the intracellular binding site, leading to an attenuated sodium channel block, which helps explain why the resulting physiological consequence can be weaker or slower in such constrained biological scenarios.

Advertisements

Dosage and Administration Information

Official Administration Guidelines

Xylocaine 5% Ointment is administered strictly by the topical route for application to the exterior surface of the skin or accessible mucous membranes. The application is designed to be external only; for anorectal use, the ointment must not be introduced into the rectum using fingers or any mechanical device.


Dosing and Frequency

For adults and children 12 years of age and older, the maximum amount applied in a single use should not exceed 5 grams of the 5% ointment, corresponding to 250 mg of lidocaine base. This preparation can be applied to the affected area up to 6 times daily. The total amount used in a 24-hour period should not exceed approximately 17 to 20 grams of ointment (1000 mg lidocaine base).


Procedural and Time Constraints

Prior to use, the area is cleansed with mild soap and warm water, rinsed, and gently dried. The ointment is intended for temporary relief and is discontinued if the condition does not show improvement within seven days. Doses are reduced for older or physically compromised patients, and use in children under 12 years of age requires consultation with a doctor. The defined single-application and daily maximums must not be exceeded.

Advertisements

Recent Clinical Evidence

Xylocaine 5%: Recent Clinical Evidence

Overview of Research

Clinical research has evaluated the properties of lidocaine (the active component in Xylocaine 5%) for its use as a local anesthetic. Lidocaine works by stabilizing the neuronal membrane, which decreases the neuron's permeability to sodium ions and, consequently, blocks the initiation and conduction of nerve impulses. Studies focus on the efficacy and safety profile of topical lidocaine formulations in various clinical settings.

Key Clinical Findings

Research has explored the role of topical lidocaine in managing localized pain conditions. Studies examining its application prior to minor procedures, such as venipuncture or superficial dermatological treatments, have reported observations regarding the reduction of procedural pain intensity compared to placebo or no treatment. The speed of observed effect is a key focus, with clinical data indicating that the onset of effect typically occurs within minutes following appropriate application.

Safety and Tolerability Observations

Clinical trials have recorded the types of adverse events associated with the topical use of lidocaine. The most commonly reported events are generally localized to the site of application and include temporary skin reactions such as erythema (redness), edema (swelling), and pruritus (itching).

Systemic absorption of lidocaine is typically low when used as directed topically on intact skin. However, studies emphasize the importance of avoiding application to large areas of broken or inflamed skin to maintain a favorable safety profile and minimize the potential for systemic exposure. Specific populations, such as those with certain cardiac or liver conditions, were subject to specific exclusion criteria in clinical trials, reflecting the need for caution.

Key Studies & References

  1. Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trial - PubMed
  2. PRESCRIBING INFORMATION XYLOCAINE OINTMENT 5% - Health Canada Regulatory Document
  3. LIDOCAINE 5% - lidocaine cream - DailyMed (FDA-associated label)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Xylocaine 5% (FAQ)


Q: Is Xylocaine 5% the same as lidocaine?

A: Xylocaine is a specific brand name for the product. According to official product information, its sole active ingredient is lidocaine hydrochloride, which belongs to a class of medicines called amide-type local anesthetics.


Q: How quickly does Xylocaine 5% usually start working?

A: Official product information suggests the onset of the numbing effect can be observed within minutes following application to mucous membranes. The medicine is designed to start working rapidly after proper topical application.


Q: How long does the numbing effect of Xylocaine 5% last?

A: The medicine is intended to provide temporary relief of pain and discomfort. The numbing effect from a single application is described as temporary, with the effect typically lasting for several hours.


Q: Can Xylocaine 5% interact with blood pressure medicine?

A: Official drug interaction information mentions potential interactions with certain medicines used to treat heart and blood pressure issues, such as Class I antiarrhythmic drugs. The documented risk highlights the importance of considering all concurrent medications.


Q: Can children or infants use Xylocaine 5%?

A: Use is not recommended for children under 2 years of age due to insufficient data. For children between 2 and 12 years, the product information states that use requires reduced, weight-based doses. Official guidance prohibits its use for infants under 12 months who are also receiving certain other medicines.


Q: Is Xylocaine 5% safe to use during pregnancy, based on official safety classifications?

A: The U.S. Food and Drug Administration (FDA) classifies the medicine under Pregnancy Category B. This designation is given when animal reproduction studies have not demonstrated a risk to the fetus, but studies examining this in pregnant women are not adequate or available.


Q: Is Xylocaine 5% absorbed into the bloodstream?

A: Yes, lidocaine may be absorbed into the bloodstream following topical administration. The extent of this systemic absorption is typically low when the medicine is used as directed on intact skin. The risk of high plasma concentrations is associated with excessive use or application to large areas of damaged skin.


Q: Can I use Xylocaine 5% if I am taking blood thinners?

A: Drug interaction information includes caution regarding certain substances, such as specific blood thinners (anticoagulants), where there is a potential for reduced metabolism of the medicine. The existence of documented interactions underscores the importance of disclosing all current medications.


Q: Does Xylocaine 5% have a maximum recommended usage area?

A: Official guidelines define the maximum single dose by weight. Patients are cautioned against applying the medicine to large areas of the body, as this significantly increases the risk of systemic absorption.


Q: Is the percentage (5%) an indicator of strength?

A: The 5% refers to the concentration of the active ingredient, lidocaine hydrochloride, in the ointment. Lidocaine products are available in a variety of concentrations for topical use.


Q: Why do people sometimes use Xylocaine 5% before medical procedures?

A: The medicine is indicated for use in clinical settings to provide surface anesthesia before minor procedures. Official product labels list its use for procedures involving the urethra and as an anesthetic lubricant for endotracheal intubation.


Q: Is Xylocaine 5% available without a prescription?

A: The regulatory status of 5% lidocaine products, meaning whether they are available over-the-counter (OTC) or require a prescription, can vary. This classification depends on the specific concentration, formulation, and the country's governing regulatory authority.


Q: Does Xylocaine 5% cause permanent numbness?

A: The medicine is designed to induce a localized and reversible interruption of nerve signals. The numbing effect is temporary, and official information does not describe this medicine as causing permanent numbness.


Q: Are there different strengths of Xylocaine besides 5%?

A: The active ingredient, lidocaine, is available in other strengths for topical application besides the 5% concentration. Other available concentrations include 2%, 4%, and higher, depending on the specific product and formulation.


Q: What happens if I forget to apply Xylocaine 5% at the recommended time?

A: If a dose is missed, patient information from official sources advises applying it as soon as possible. If it is nearly time for the next scheduled application, skipping the missed dose and resuming the regular schedule is advised in patient information.


Q: Can Xylocaine 5% be used near the eyes or mouth?

A: Safety guidelines explicitly warn against allowing the medicine to contact the eyes. Use in or near the mouth and other sensitive areas is restricted and requires specific guidance.


Q: Are there any known interactions between Xylocaine 5% and herbal supplements?

A: Regulatory testing and information on co-administration with herbal supplements are generally lacking. Caution is warranted, as authoritative health body information states there is insufficient data to confirm safety.


Q: Does using Xylocaine 5% affect driving or operating machinery?

A: If the medicine is absorbed excessively, it can lead to Central Nervous System (CNS) side effects. These reactions, such as lightheadedness and drowsiness, are documented in official safety profiles and may potentially impair a person’s ability to drive or use machinery.


Q: Is Xylocaine 5% considered a controlled substance?

A: No, the active ingredient, lidocaine hydrochloride, is a local anesthetic. It is not listed as a controlled substance by the U.S. Drug Enforcement Administration (DEA) or other major regulatory bodies.


Q: Does Xylocaine 5% have any effect on blood glucose levels?

A: Changes in blood glucose levels are not listed as an adverse effect on the medicine's official safety profile. The primary concern for blood sugar effects with local anesthetics typically relates to formulations that contain epinephrine, which this product does not.


Q: Does Xylocaine 5% have a known impact on fertility?

A: Non-clinical data from the medicine's official labeling, based on animal studies, did not indicate any alteration in the fertility or reproductive performance of male or female rats. Studies examining the impact on fertility in humans are not adequate or available.


Q: Can using Xylocaine 5% lead to skin discoloration?

A: Skin changes such as paleness or blanching at the application site have been reported as local side effects. Bluish-colored lips, nails, or skin are documented signs of Methemoglobinemia, a rare blood disorder associated with the medicine.


Q: What are the official recommendations about accidental ingestion of Xylocaine 5%?

A: Accidental ingestion can lead to serious adverse effects due to rapid systemic absorption. In the event of suspected ingestion, the official safety recommendation is to immediately seek medical assistance, such as contacting a Poison Control Center.


Q: Is Xylocaine 5% used for joint pain?

A: The official indication is for surface anesthesia and dermal analgesia. General joint pain is not an explicitly listed indication for this topical product.


Q: What regulatory bodies have approved Xylocaine 5%?

A: The medicine and its generic forms are approved for use by major governmental and intergovernmental bodies globally. These include the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the Australian Therapeutic Goods Administration (TGA).


Q: Can Xylocaine 5% interact with psychiatric medications?

A: Official drug interaction information documents a potential for interaction with certain categories of psychiatric medications, such as antidepressants. This interaction is noted due to an increased risk of additive systemic effects.


Q: Can Xylocaine 5% be used for itching or rashes?

A: The official indications include the temporary relief of pain and itching (pruritus) associated with minor burns, insect bites, and certain anorectal disorders.


Q: Is a slight stinging sensation normal right after applying Xylocaine 5%?

A: Common and temporary local reactions at the application site are documented in official safety profiles. These documented reactions include a burning sensation, irritation, and redness (erythema).


Q: Is Xylocaine 5% used in hospital settings?

A: The active ingredient, lidocaine, in various forms, is a common local anesthetic used in clinical and hospital settings. It is specifically indicated for use in hospitals for certain minor procedures and for providing topical anesthesia.


Q: What is the difference between Xylocaine and lidocaine patches?

A: The difference lies in the dosage form and route of administration. Xylocaine 5% is an ointment that is applied directly to the skin, while lidocaine patches are a different preparation designed to be applied to and worn on the skin for a period of time.


Q: Can Xylocaine 5% be used with heat packs or heating pads?

A: Official safety warnings state that the use of external heat sources, such as heating pads or electric blankets, over the application site should be avoided. External heat can increase the medicine's systemic absorption and significantly raise the risk of serious side effects.


Q: Are headaches a known side effect of Xylocaine 5%?

A: Headache is listed in post-marketing reports as an adverse event associated with the medicine. It is also noted as a potential sign of a serious systemic reaction, such as Methemoglobinemia, if high absorption occurs.


Q: Is there a risk of overdose or using too much Xylocaine 5%?

A: Official warnings state that exceeding the maximum recommended dosage or using the medicine too frequently can result in high systemic levels. Exceeding recommended use can result in serious adverse effects, which may include toxic exposure or life-threatening systemic reactions.

Advertisements

How should Xylocaine 5% be stored and disposed of?

Storage and Disposal Requirements for Xylocaine 5% Ointment

Official regulations require Xylocaine 5% Ointment to be stored at Controlled Room Temperature, specifically between 20 C and 25 C (68 F and 77 F). It is mandatory to keep the product from freezing and to store it in a tightly closed container to ensure stability.

Labeled Storage Summary

Condition Requirement (Official Labeling)
Temperature Controlled Room Temp (20 C–25 C)
Freezing Do not freeze
Container Keep in a tight container
Child Safety Keep out of the reach of children

Any unused or expired ointment must be disposed of according to local regulations. Consumers are advised to utilize official drug take-back programs or follow specific guidelines for mixing the product with an undesirable substance before discarding it in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Xylocaine 5% found in:

A-Z Index: